Biotin Anti-Cytokeratin 8 antibody [SP102] - C-terminal,Abcam,AB322309
Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .
Host
Rabbit
Reactivity
Human, Human, Mouse, Rat
Application
IHC-P
Conjugate
Biotin
Platform ID
BAB539741473
Abcam
Contact
Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215
Email:
Product Specifications
Scientific Background
Specifications
NameBiotin Anti-Cytokeratin 8 antibody [SP102] - C-terminal
Cat. No.AB322309
HostRabbit
IsotypeIgG
ReactivityHuman, Human, Mouse, Rat
ConjugationBiotin
ApplicationIHC-P
ClonalityMonoclonal
Clone NumberSP102
ImmunogenThe exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Protein A/G
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 30% Glycerol (glycerin, glycerine), 1% BSA
Storage-20°C
Regulatory StatusResearch Use Only
Scientific Background
Target data Together with KRT19, helps to link the contractile apparatus to dystrophin at the costameres of striated muscle. See full target information KRT8
Category Paths
- Products>Primary Antibodies>Monoclonal Antibodies
- Products>Primary Antibodies>IHC Antibodies
- Products>Primary Antibodies>Recombinant Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.